Adaptimmune Therapeutics PLC (ADAPY) Net Margin (2015 - 2025)
Adaptimmune Therapeutics (ADAPY) recorded Net Margin of -221.83% in Q2 2025, down 276.05 percentage points from 54.22% a year earlier but up 431.35 percentage points from the prior quarter.
Powered by 
Analysis
Adaptimmune Therapeutics PLC (ADAPY) Net Margin (2015 - 2025) Analysis & Trends
On a TTM basis, Adaptimmune Therapeutics' Net Margin came in at -154.01% as of Jun 30, 2025, down 102.75 percentage points year-over-year; for FY2024, it was -39.78%, up 149.12 percentage points from FY2023.
- Annual Net Margin has increased for five straight years, with a five-year change of +12185.27 percentage points (FY2019 to FY2024).
- Across earlier years, Net Margin came in at -188.90% in FY2023 (+420.56 pp), -609.46% in FY2022 (+1961.53 pp), -2570.99% in FY2021 (+715.82 pp) and -3286.81% in FY2020 (+8938.23 pp).
- Quarterly Net Margin has ranged from -20743.29% in Q4 2023 to 169.97% in Q3 2024 over the past five years.
- On a year-over-year basis, Net Margin rose in four of the last eight quarters, with an average year-over-year change of -285.51 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 17893.13 percentage points in Q4 2024, against a drop of 20478.06 percentage points in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -653.18% (Q1 2025), -2850.16% (Q4 2024) and 169.97% (Q3 2024).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -221.83% |
| Mar 31, 2025 | -653.18% |
| Dec 31, 2024 | -2,850.16% |
| Sep 30, 2024 | 169.97% |
| Jun 30, 2024 | 54.22% |
| Mar 31, 2024 | -854.23% |
| Dec 31, 2023 | -20,743.29% |
| Sep 30, 2023 | -623.05% |
| Jun 30, 2023 | -416.94% |
| Mar 31, 2023 | 2.18% |
| Dec 31, 2022 | -265.23% |
| Sep 30, 2022 | -591.14% |
| Jun 30, 2022 | -803.90% |
| Mar 31, 2022 | -1,406.01% |
| Dec 31, 2021 | -2,742.27% |
| Sep 30, 2021 | -3,524.61% |
| Jun 30, 2021 | -1,262.29% |
| Mar 31, 2021 | -8,701.15% |
| Dec 31, 2020 | -2,437.62% |
| Sep 30, 2020 | -2,969.99% |
API Access
Adaptimmune Therapeutics PLC Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ADAPY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ADAPY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ADAPY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();